Tuberculosis vaccine candidate testing
Ended Awarded Last action
- Contract number
- 75N91018F00068
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,752,224
Award facts
- Opportunity
-
- N01CO5240180 Solicitation number
- Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC) Award Notice · Posted Apr 27, 2015
- Contract value 100% obligated
- $3,752,224.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $3,752,224 |
About this award
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $3,752,224.00 cost-plus-fixed-fee delivery order contract to Leidos Biomedical Research Inc. for the testing of a tuberculosis vaccine candidate. The contract has a completion date of September 23, 2023 and was awarded on September 24, 2018. Leidos Biomedical Research Inc. is a subsidiary of the Leidos Holdings, Inc. conglomerate that provides research, development, and production services to federal agencies. This award is not associated with any set-aside program. Leidos Biomedical Research has a broad history of supporting biomedical research programs at the NIH, including work in cancer, HIV/AIDS, influenza, and COVID-19.
Quick answers
Who was awarded contract 75N91018F00068?
75N91018F00068 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 24, 2018.
How much is contract 75N91018F00068 worth?
The government has obligated $3,752,224 on 75N91018F00068.
Which agency awarded contract 75N91018F00068?
National Cancer Institute (National Institutes of Health) awarded 75N91018F00068, with funding from National Institute of Allergy and Infectious Diseases (National Institutes of Health).
Is contract 75N91018F00068 an order under another contract?
Yes. 75N91018F00068 is a delivery order under HHSN261201500003I, an indefinite delivery contract.
Was contract 75N91018F00068 competed?
The extent of competition for 75N91018F00068 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award